Gall Stone
13
2
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (13)
Laparoendoscopic Rendezvous for Concomitant Gall Bladder Stones and Common Bile Duct Stones
Benchmarks in Elective Laparoscopic Cholecystectomy
Benchmarks in Acute Laparoscopic Cholecystectomy
Genetic Variants Associated With the Risk of Gall Stones and Cirrhosis.
ALgerian Cholecystectomy Outcomes and Determinants Study (AL-CODS)
Influence of Gut Microbiome in Gallstone Disease
The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract Diseases
Norwegian Randomized Trial on Indocyanine Green Cholangiography Utility for Laparoscopic Cholecystectomy, Prestudy
RISK FACTORS OF GALL BLADDER STONE
Are There Dietary Factors Affecting the Development of Pancreatitis in Patients With Gallstones?
Colonic Gallstone Ileus, Diagnostic-therapeutic Algorithm
A Retrospective and Prospective Cohort Study of the 21-day Fasting-like Diet in Patients With Metabolic and Autoimmune Diseases
Bile Composition in Healthy and Gallstones Patients